<prompt> A 63-year-old woman with Type 2 diabetes is seen for follow-up after a fasting lipid profile. She has no other medical conditions and feels well. Her diabetes is well controlled and the last hemoglobin A1C value was 6.5. Her total cholesterol T-chol is 240 mgdL, HDL50 mgdL, low-density lipoprotein LDL 160 mgdL, and triglycerides 150 mgdL.For the above patient with dyslipidemia, select the most appropriate treatment.fibric acid derivatives clofibrate, gemfibrozilnicotinic acidbile acid-binding resins cholestyramine, colestipolhepatic hydroxymethylglutaryl coenzyme A HMG-CoA reductase inhibitors lovastatin, simvastatin, pravastatin  <response>: Patients with diabetes have the same rates of coronary heart disease events as patients with established CAD. Therefore, diabetes is now considered a coronary heart disease equivalent when assessing risk even if the patient has not had any previous cardiac symptoms. The current guidelines support risk reduction efforts both lifestyle and drug therapy in patients with diabetes similar to those recommended for patients with CAD secondary prevention. The goal for LDL is 100 mgdL in patients with diabetes and secondary goals include considering fibrates for those with high triglycerides and nicotinic acid for low HDL cholesterol. Lifestyle modification is recommended for everyone irrespective of risk. 